599 related articles for article (PubMed ID: 22823866)
61. Circadian Disruption Reveals a Correlation of an Oxidative GSH/GSSG Redox Shift with Learning and Impaired Memory in an Alzheimer's Disease Mouse Model.
LeVault KR; Tischkau SA; Brewer GJ
J Alzheimers Dis; 2016; 49(2):301-16. PubMed ID: 26484899
[TBL] [Abstract][Full Text] [Related]
62. Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD.
Verma M; Beaulieu-Abdelahad D; Ait-Ghezala G; Li R; Crawford F; Mullan M; Paris D
PLoS One; 2015; 10(5):e0128224. PubMed ID: 26010758
[TBL] [Abstract][Full Text] [Related]
63. Inhibition of c-Jun N-terminal kinase activation reverses Alzheimer disease phenotypes in APPswe/PS1dE9 mice.
Zhou Q; Wang M; Du Y; Zhang W; Bai M; Zhang Z; Li Z; Miao J
Ann Neurol; 2015 Apr; 77(4):637-54. PubMed ID: 25611954
[TBL] [Abstract][Full Text] [Related]
64. Dietary supplementation of walnuts improves memory deficits and learning skills in transgenic mouse model of Alzheimer's disease.
Muthaiyah B; Essa MM; Lee M; Chauhan V; Kaur K; Chauhan A
J Alzheimers Dis; 2014; 42(4):1397-405. PubMed ID: 25024344
[TBL] [Abstract][Full Text] [Related]
65. Mitochondrial biogenesis mediated by melatonin in an APPswe/PS1dE9 transgenic mice model.
Song C; Li M; Xu L; Shen Y; Yang H; Ding M; Liu X; Xie Z
Neuroreport; 2018 Dec; 29(18):1517-1524. PubMed ID: 30303857
[TBL] [Abstract][Full Text] [Related]
66. Altered expression of the CB1 cannabinoid receptor in the triple transgenic mouse model of Alzheimer's disease.
Bedse G; Romano A; Cianci S; Lavecchia AM; Lorenzo P; Elphick MR; Laferla FM; Vendemiale G; Grillo C; Altieri F; Cassano T; Gaetani S
J Alzheimers Dis; 2014; 40(3):701-12. PubMed ID: 24496074
[TBL] [Abstract][Full Text] [Related]
67. Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms.
Dubocovich ML; Yun K; Al-Ghoul WM; Benloucif S; Masana MI
FASEB J; 1998 Sep; 12(12):1211-20. PubMed ID: 9737724
[TBL] [Abstract][Full Text] [Related]
68. Early development of social deficits in APP and APP-PS1 mice.
Pietropaolo S; Delage P; Lebreton F; Crusio WE; Cho YH
Neurobiol Aging; 2012 May; 33(5):1002.e17-27. PubMed ID: 22014620
[TBL] [Abstract][Full Text] [Related]
69. Neuroprotective role of trans-resveratrol in a murine model of familial Alzheimer's disease.
Porquet D; Griñán-Ferré C; Ferrer I; Camins A; Sanfeliu C; Del Valle J; Pallàs M
J Alzheimers Dis; 2014; 42(4):1209-20. PubMed ID: 25024312
[TBL] [Abstract][Full Text] [Related]
70. Effects of gintonin-enriched fraction on hippocampal cell proliferation in wild-type mice and an APPswe/PSEN-1 double Tg mouse model of Alzheimer's disease.
Kim HJ; Kim DJ; Shin EJ; Lee BH; Choi SH; Hwang SH; Rhim H; Cho IH; Kim HC; Nah SY
Neurochem Int; 2016 Dec; 101():56-65. PubMed ID: 27765516
[TBL] [Abstract][Full Text] [Related]
71. Melatonin receptor activation suppresses adrenocorticotropin production via BMP-4 action by pituitary AtT20 cells.
Tsukamoto N; Otsuka F; Ogura-Ochi K; Inagaki K; Nakamura E; Toma K; Terasaka T; Iwasaki Y; Makino H
Mol Cell Endocrinol; 2013 Aug; 375(1-2):1-9. PubMed ID: 23701823
[TBL] [Abstract][Full Text] [Related]
72. MT1 melatonin receptors mediate somatic, behavioral, and reproductive neuroendocrine responses to photoperiod and melatonin in Siberian hamsters (Phodopus sungorus).
Prendergast BJ
Endocrinology; 2010 Feb; 151(2):714-21. PubMed ID: 19966183
[TBL] [Abstract][Full Text] [Related]
73. Effect of MT1 melatonin receptor deletion on melatonin-mediated phase shift of circadian rhythms in the C57BL/6 mouse.
Dubocovich ML; Hudson RL; Sumaya IC; Masana MI; Manna E
J Pineal Res; 2005 Sep; 39(2):113-20. PubMed ID: 16098087
[TBL] [Abstract][Full Text] [Related]
74. Mithramycin A Alleviates Cognitive Deficits and Reduces Neuropathology in a Transgenic Mouse Model of Alzheimer's Disease.
Wei C; Zhang W; Zhou Q; Zhao C; Du Y; Yan Q; Li Z; Miao J
Neurochem Res; 2016 Aug; 41(8):1924-38. PubMed ID: 27072684
[TBL] [Abstract][Full Text] [Related]
75. Cardiotrophin-1 (CTF1) ameliorates glucose-uptake defects and improves memory and learning deficits in a transgenic mouse model of Alzheimer's disease.
Wang D; Li X; Gao K; Lu D; Zhang X; Ma C; Ye F; Zhang L
Pharmacol Biochem Behav; 2013 Jun; 107():48-57. PubMed ID: 23541490
[TBL] [Abstract][Full Text] [Related]
76. Melatonin plus physical exercise are highly neuroprotective in the 3xTg-AD mouse.
García-Mesa Y; Giménez-Llort L; López LC; Venegas C; Cristòfol R; Escames G; Acuña-Castroviejo D; Sanfeliu C
Neurobiol Aging; 2012 Jun; 33(6):1124.e13-29. PubMed ID: 22177720
[TBL] [Abstract][Full Text] [Related]
77. Behavioral and SCN neurophysiological disruption in the Tg-SwDI mouse model of Alzheimer's disease.
Paul JR; Munir HA; van Groen T; Gamble KL
Neurobiol Dis; 2018 Jun; 114():194-200. PubMed ID: 29540298
[TBL] [Abstract][Full Text] [Related]
78. [Effects of physical exercise on cognitive alterations and oxidative stress in an APP/PSN1 transgenic model of Alzheimer's disease].
Pareja-Galeano H; Brioche T; Sanchís-Gomar F; Escrivá C; Dromant M; Gómez-Cabrera MC; Viña J
Rev Esp Geriatr Gerontol; 2012; 47(5):198-204. PubMed ID: 22884639
[TBL] [Abstract][Full Text] [Related]
79. Effects of melatonin in two individuals with Alzheimer's disease.
Jean-Louis G; Zizi F; von Gizycki H; Taub H
Percept Mot Skills; 1998 Aug; 87(1):331-9. PubMed ID: 9760668
[TBL] [Abstract][Full Text] [Related]
80. The Rhythmicity of Clock Genes is Disrupted in the Choroid Plexus of the APP/PS1 Mouse Model of Alzheimer's Disease.
Furtado A; Astaburuaga R; Costa A; Duarte AC; Gonçalves I; Cipolla-Neto J; Lemos MC; Carro E; Relógio A; Santos CRA; Quintela T
J Alzheimers Dis; 2020; 77(2):795-806. PubMed ID: 32741824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
